Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Income 1 Regulatory News (MIG1)

Share Price Information for Maven Income 1 (MIG1)

Share Price is delayed by 15 minutes
Get Live Data
33.80    0.00 (0.00%)
Bid:
32.80
Ask:
34.80
Spread: 2.00 (6.098%)
Market Cap: £70.05m
MIG1 Live PriceLast checked at - London Stock Exchange

Intraday Maven Income 1 Share Chart

Annual Information Update

30 May 2007 17:19

Murray VCT 4 PLC30 May 2007 MURRAY VCT 4 PLC ANNUAL INFORMATION UPDATE Pursuant to the requirements of Prospectus Rule 5.2, the following summarisesthe information that has been published or made available to the public by theCompany throughout the twelve months ended 30 May 2007. Some of the information referred to below was provided as at a specific dateand, therefore, may now be out of date. Date Place of Filing or Publication Description 5 June 2006 London Stock Exchange via RNS Annual Report and Financial Statements UKLA Document Viewing Facility5 June 2006 London Stock Exchange via RNS Annual Information Update14 June 2006 Companies House Form 1699 June 2006 London Stock Exchange via RNS Purchase of Own Shares27 June 2006 Companies House Form 16927 June 2006 Companies House Form 16927 June 2006 Companies House Annual Report and Financial Statements27 June 2006 Companies House Form 288c6 July 2006 London Stock Exchange via RNS Result of Annual General Meeting12 July 2006 Companies House Resolutions of Annual General Meeting31 August 2006 London Stock Exchange via RNS Purchase of Own Shares26 September 2006 Companies House Form 1698 November 2006 London Stock Exchange via RNS Interim Announcement15 November 2006 London Stock Exchange via RNS Purchase of Own Shares8 December 2006 Companies House Form 16914 December 2006 Companies House Interim Report and Financial Statements UKLA Document Viewing Facility20 December 2006 London Stock Exchange via RNS Total Voting Rights24 January 2007 London Stock Exchange via RNS Dividend Declaration26 January 2007 London Stock Exchange via RNS Directorate Change2 February 2007 London Stock Exchange via RNS Director/PDMR Shareholding23 February 2007 Companies House Form 363a12 March 2007 Companies House Form 288a26 April 2007 London Stock Exchange via RNS Preliminary Announcement30 April 2007 London Stock Exchange via RNS Director/PDMR Shareholding30 May 2007 London Stock Exchange via RNS Annual Report and Financial Statements UKLA Document Viewing Facility30 May 2007 London Stock Exchange via RNS Annual Information Update Announcements listed as published on the London Stock Exchange have beenpublished via a Regulatory Information Service and can be found onwww.londonstockexchange.com. Copies of documents filed at Companies House can beobtained from Companies House or through Companies House Direct atwww.direct.companieshouse.gov.uk. Further details may also be obtained from thewebsite of the Company's Manager (www.aberdeen-asset.com). Annual and Interim Reports and Financial Statements can also be inspected at theUK Listing Authority's Document Viewing Facility at: Financial Services Authority25 The North ColonnadeCanary WharfLondon E14 5HSTel. 020 7676 1000 For further information on any of the above, please contact: David Russell, Company Secretary - Growth CapitalAberdeen Asset Management PLCTelephone: 0141 306 7555E-mail: david.russell@aberdeen-asset.com Issued on behalf of the BoardMurray Johnstone Limited, Secretary30 May 2007 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Jun 20264:19 pmRNSAnnual Financial Report
1st May 20263:20 pmRNSTransaction in Own Shares
30th Apr 20265:09 pmRNSTransaction in Own Shares
30th Apr 202610:51 amRNSAdmission of Further Securities to Trading
29th Apr 202612:23 pmRNSIssue of Equity
27th Apr 20263:29 pmRNSUnaudited Net Asset Value and Dividend Declaration
20th Apr 202612:23 pmRNSPublication of a Supplementary Prospectus
15th Apr 202611:17 amRNSAdmission of Further Securities to Trading
14th Apr 202611:06 amRNSIssue of Equity
8th Apr 20269:27 amRNSAdmission of Further Securities to Trading
25th Mar 202610:49 amRNSAdmission of Further Securities to Trading
24th Mar 202612:08 pmRNSIssue of Equity
4th Feb 20267:00 amRNSStatement re Offer for Subscription
29th Jan 20264:54 pmRNSTransaction in Own Shares
21st Jan 202611:01 amRNSAdmission of Further Securities to Trading
20th Jan 20262:05 pmRNSAdmission of Further Securities to Trading
16th Jan 20269:39 amRNSIssue of Equity
15th Jan 202610:27 amRNSDirector/PDMR Shareholding
15th Jan 202610:26 amRNSDirector/PDMR Shareholding
15th Jan 202610:26 amRNSDirector/PDMR Shareholding
15th Jan 20269:50 amRNSIssue of Equity
14th Jan 20262:33 pmRNSUnaudited NAV - Dividend Investment Scheme
4th Dec 202510:35 amRNSUnaudited NAV and Second Interim Dividend
13th Nov 20253:39 pmRNSResult of General Meeting
29th Oct 20257:00 amRNSHalf-year Report
16th Oct 20254:43 pmRNSTransaction in Own Shares
2nd Oct 20254:42 pmRNSPublication of a Prospectus
15th Sep 20251:06 pmRNSNet Asset Value(s)
29th Aug 20257:00 amRNSIssue of Equity
20th Aug 20252:12 pmRNSStatement re Dividend Investment Scheme
23rd Jul 20254:33 pmRNSTransaction in Own Shares
18th Jul 202510:08 amRNSIssue of Equity - Dividend Investment Scheme
16th Jul 20257:08 amRNSStatement re Offer for Subscription
11th Jul 20253:56 pmRNSStatement re Dividend Investment Scheme
11th Jul 20252:58 pmRNSStatement re Unaudited NAV and Interim Dividend
10th Jul 20252:32 pmRNSResult of AGM
28th May 20254:18 pmRNSAnnual Financial Report
7th May 20254:35 pmRNSTransaction in Own Shares
6th May 202511:51 amRNSIssue of Equity
25th Apr 20254:19 pmRNSUnaudited NAV and Proposed Final Dividend
17th Apr 202512:56 pmRNSPublication of Suppl.Prospcts
7th Apr 20257:00 amRNSIssue of Equity - Replacement
4th Apr 20256:15 pmRNSIssue of Equity
1st Apr 202512:59 pmRNSStatement re Offers for Subscription - Closed
27th Mar 20251:02 pmRNSIssue of Equity
27th Mar 202510:25 amRNSUpdate re: Offers for Subscription
24th Mar 20253:23 pmRNSUnaudited Net Asset Value
29th Jan 20254:35 pmRNSTransaction in Own Shares
28th Jan 202512:15 pmRNSStatement re Offer for Subscription
28th Jan 202511:27 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.